EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Predicting Prognosis and Platinum Resistance in Ovarian Cancer: Role of Immunohistochemistry Biomarkers

Ghofraan Abdulsalam Atallah, Nirmala Chandralega Kampan iD, Kah Teik Chew iD, Norfilza Mohd Mokhtar iD, Reena Rahayu Md Zin, Mohamad Nasir Bin Shafiee iD, Nor Haslinda Binti Abd Aziz

International Journal of Molecular Sciences · 19.01.2023 · 24 (3) · 1973

DOI: 10.3390/ijms24031973 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.01.2023. Verfasst von Ghofraan Abdulsalam Atallah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Faculty of Medicine, University Kebangsaan Malaysia, Bandar Tun Razak 56000, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Ovarian Neoplasms. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Grant Scheme by the Ministry of Higher Education Malaysia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer is a lethal reproductive tumour affecting women worldwide. The advancement in presentation and occurrence of chemoresistance are the key factors for poor survival among ovarian cancer women. Surgical debulking was the mainstay of systemic treatment for ovarian cancer, which was followed by a successful start to platinum-based chemotherapy. However, most women develop platinum resistance and relapse within six months of receiving first-line treatment. Thus, there is a great need to identify biomarkers to predict platinum resistance before enrolment into chemotherapy, which would facilitate individualized targeted therapy for these subgroups of patients to ensure better survival and an improved quality of life and overall outcome. Harnessing the immune response through immunotherapy approaches has changed the treatment way for patients with cancer. The immune outline has emerged as a beneficial tool for recognizing predictive and prognostic biomarkers clinically. Studying the tumour microenvironment (TME) of ovarian cancer tissue may provide awareness of actionable targets for enhancing chemotherapy outcomes and quality of life. This review analyses the relevance of immunohistochemistry biomarkers as prognostic biomarkers in predicting chemotherapy resistance and improving the quality of life in ovarian cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsFemaleHumansPlatinumQuality of LifeImmunohistochemistryNeoplasm Recurrence, LocalBiomarkersDrug Resistance, NeoplasmBiomarkers, TumorTumor Microenvironment

Stichwörter der Autor:innen

biomarkerschemotherapy resistancedisease relapseimmunohistochemistryovarian cancerplatinum chemotherapy

Substanzen

PlatinumBiomarkersBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, Faculty of Medicine, University Kebangsaan Malaysia, Bandar Tun Razak 56000, Kuala Lumpur, Malaysia.
  • Department of Physiology, Faculty of Medicine, University Kebangsaan Malaysia, Bandar Tun Razak 56000, Kuala Lumpur, Malaysia.
  • Department of Pathology, Faculty of Medicine, University Kebangsaan Malaysia, Bandar Tun Razak 56000, Kuala Lumpur, Malaysia.

ORCID-Profile: Nirmala Chandralega Kampan, Kah Teik Chew, Norfilza Mohd Mokhtar, Mohamad Nasir Bin Shafiee

Förderung

  • Fundamental Research Grant Scheme by the Ministry of Higher Education Malaysia

Zitieren

APA

Atallah, G. A., Kampan, N. C., Chew, K. T., Mohd Mokhtar, N., Md Zin, R. R., Shafiee, M. N. B., & Abd Aziz, N. H. B. (2023). Predicting Prognosis and Platinum Resistance in Ovarian Cancer: Role of Immunohistochemistry Biomarkers. International Journal of Molecular Sciences, 24(3), 1973. https://doi.org/10.3390/ijms24031973

Vancouver

Atallah GA, Kampan NC, Chew KT, Mohd Mokhtar N, Md Zin RR, Shafiee MNB, et al. Predicting Prognosis and Platinum Resistance in Ovarian Cancer: Role of Immunohistochemistry Biomarkers. International Journal of Molecular Sciences. 2023;24(3):1973. doi:10.3390/ijms24031973

BibTeX
@article{Atallah2023,
  author = {Atallah, Ghofraan Abdulsalam and Kampan, Nirmala Chandralega and Chew, Kah Teik and Mohd Mokhtar, Norfilza and Md Zin, Reena Rahayu and Shafiee, Mohamad Nasir Bin and Abd Aziz, Nor Haslinda Binti},
  title = {Predicting Prognosis and Platinum Resistance in Ovarian Cancer: Role of Immunohistochemistry Biomarkers},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {3},
  pages = {1973},
  doi = {10.3390/ijms24031973}
}
Kostenlos starten →